Biotalys: Biofungicide EVOCA Gains First Approval in the United States
Biotalys has announced via press release that its innovative biofungicide, EVOCA, has been registered in the state of Florida. This marks the first approval of an AGROBODY biocontrol by a U.S. state.
First Approval for AGROBODY Technology in the United States
The Florida Department of Agriculture has approved EVOCA based on the broad spectrum of use previously approved by the U.S. Environmental Protection Agency (EPA). This protein-based biofungicide helps control key fungal diseases such as Botrytis and powdery mildew in fruits and vegetables. Carlo Boutton, interim CEO of Biotalys, emphasizes that Florida is the second largest U.S. state in terms of production of key fruits and vegetables such as strawberries, tomatoes, and bell peppers.
Regulatory Progress in California and Europe
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
In California, the Department of Pesticide Regulation continues its review of EVOCA, with its Human Health Assessment Department having accepted the EPA-approved label. Approval is currently projected for the second half of 2026. In Europe, the regulatory review is progressing with a two-month public consultation phase set to launch this week. The European Food Safety Authority (EFSA) and the Dutch Board for the Authorisation of Plant Protection Products (CTGB) will then review the comments before the file proceeds to the decision phase.
Biotalys intends to maintain a cost-conscious approach to fully exploit the potential of its unique technology platform
Risks mentioned
Limited financial runway of only until end of Q1 2027 requiring additional financing
Regulatory approval delays in U.S. and E.U. for EVOCA and EVOCA NG could impact commercialisation timeline
Dependence on successful manufacturing scale-up and partnerships to achieve commercial viability of lead products
Opportunities identified
Regulatory approval pathway for EVOCA NG in U.S. (2029 launch) and Europe (2030 launch) targeting USD 1.1 billion market
BioFun-6 lead candidate demonstrating strong efficacy in field trials across multiple crops and geographies
Strategic partnership with 21st.BIO for manufacturing efficiencies and commercially competitive cost structure
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
